Natixis Ligand Pharmaceuticals Inc Transaction History

Natixis

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$113.03 - $155.64 $1.25 Million - $1.73 Million	-11,100 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$99.52 - $215.83 $550,246 - $1.19 Million	5,529 Added 99.25%	11,100 $1.69 Million
Q2 2019 Aug 13, 2019	BUY	$107.38 - $129.34 $598,213 - $720,553	5,571 New	5,571 $636,000

256

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.95B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.